282 related articles for article (PubMed ID: 2503536)
1. Depot leuprolide acetate for treatment of precocious puberty.
Parker KL; Lee PA
J Clin Endocrinol Metab; 1989 Sep; 69(3):689-91. PubMed ID: 2503536
[TBL] [Abstract][Full Text] [Related]
2. Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty.
Kappy M; Stuart T; Perelman A; Clemons R
J Clin Endocrinol Metab; 1989 Nov; 69(5):1087-9. PubMed ID: 2507570
[TBL] [Abstract][Full Text] [Related]
3. Effects of leuprolide in the treatment of central precocious puberty.
Lee PA; Page JG
J Pediatr; 1989 Feb; 114(2):321-4. PubMed ID: 2492599
[TBL] [Abstract][Full Text] [Related]
4. Depot leuprolide acetate dosage for sexual precocity.
Parker KL; Baens-Bailon RG; Lee PA
J Clin Endocrinol Metab; 1991 Jul; 73(1):50-2. PubMed ID: 1904452
[TBL] [Abstract][Full Text] [Related]
5. A dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (leuprolide acetate depot, TAP-144-SR) in the treatment of central precocious puberty. The TAP-144-SR CPP Study Group.
Tanaka T; Hibi I; Kato K; Saito S; Shimizu N; Suwa S; Nakajima H
Endocrinol Jpn; 1991 Aug; 38(4):369-76. PubMed ID: 1839379
[TBL] [Abstract][Full Text] [Related]
6. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
Neely EK; Hintz RL; Parker B; Bachrach LK; Cohen P; Olney R; Wilson DM
J Pediatr; 1992 Oct; 121(4):634-40. PubMed ID: 1403402
[TBL] [Abstract][Full Text] [Related]
7. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
Clemons RD; Kappy MS; Stuart TE; Perelman AH; Hoekstra FT
Am J Dis Child; 1993 Jun; 147(6):653-7. PubMed ID: 8506834
[TBL] [Abstract][Full Text] [Related]
8. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.
Brito VN; Latronico AC; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2004 Sep; 89(9):4338-42. PubMed ID: 15356030
[TBL] [Abstract][Full Text] [Related]
9. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
[TBL] [Abstract][Full Text] [Related]
10. Serum luteinizing hormone rises within minutes after depot leuprolide injection: implications for monitoring therapy.
Bhatia S; Neely EK; Wilson DM
Pediatrics; 2002 Feb; 109(2):E30. PubMed ID: 11826240
[TBL] [Abstract][Full Text] [Related]
11. Treatment of central precocious puberty: comparison of urinary gonadotropin excretion and gonadotropin-releasing hormone (GnRH) stimulation tests in monitoring GnRH analog therapy.
Witchel SF; Baens-Bailon RG; Lee PA
J Clin Endocrinol Metab; 1996 Apr; 81(4):1353-6. PubMed ID: 8636332
[TBL] [Abstract][Full Text] [Related]
12. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of leuprolide therapy in children with central precocious puberty.
Kappy MS; Stuart T; Perelman A
Am J Dis Child; 1988 Oct; 142(10):1061-4. PubMed ID: 3140654
[TBL] [Abstract][Full Text] [Related]
14. Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty.
Badaru A; Wilson DM; Bachrach LK; Fechner P; Gandrud LM; Durham E; Wintergerst K; Chi C; Klein KO; Neely EK
J Clin Endocrinol Metab; 2006 May; 91(5):1862-7. PubMed ID: 16449344
[TBL] [Abstract][Full Text] [Related]
15. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone.
Pescovitz OH; Hench KD; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1988 Sep; 67(3):474-9. PubMed ID: 3137242
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty.
Crowley WF; Comite F; Vale W; Rivier J; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1981 Feb; 52(2):370-2. PubMed ID: 6780592
[TBL] [Abstract][Full Text] [Related]
17. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of precocious puberty with an LH-RH agonist (D-TRP6-LH-RH delayed-release microcapsules)].
Canlorbe P; Chaussain JL; Lahlou N; Roger M; Toublanc JE; Job JC
Bull Acad Natl Med; 1988 Nov; 172(8):1091-8. PubMed ID: 2977732
[No Abstract] [Full Text] [Related]
19. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
[TBL] [Abstract][Full Text] [Related]
20. The Use of Morning Urinary Gonadotropins and Sex Hormones in the Management of Early Puberty in Chinese Girls.
Zhan S; Huang K; Wu W; Zhang D; Liu A; Dorazio RM; Shi J; Ullah R; Zhang L; Wang J; Dong G; Ni Y; Fu J
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4520-e4530. PubMed ID: 34160619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
